Banque Cantonale Vaudoise’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-10,197
Closed -$477K – 1252
2021
Q1
$477K Buy
+10,197
New +$494K 0.02% 554

Other funds holding HCAT

Banque Cantonale Vaudoise's HCAT Position: Q2 2021 in Review

Banque Cantonale Vaudoise sold out of Health Catalyst (HCAT) in Q2 2021, closing a stake of 10,197 shares — an estimated $477K sold.

Banque Cantonale Vaudoise first reported a position in HCAT in Q1 2021 and held it in 1 quarter. The position peaked at $477K in Q1 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q2 2021.

  • Banque Cantonale Vaudoise reported no remaining Health Catalyst position as of Q2 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 10,197 Health Catalyst shares in Q2 2021, an estimated $477K.
  • Banque Cantonale Vaudoise first reported a position in Health Catalyst in Q1 2021 and held it in 1 quarter.
  • Banque Cantonale Vaudoise's Health Catalyst position peaked at $477K in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2021, filed 11 Aug 2021.